{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:07:19Z","timestamp":1774436839422,"version":"3.50.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.amjmed.2014.05.010","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T04:30:30Z","timestamp":1400560230000},"page":"886.e1-886.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Pneumococcal Vaccine and Patients with Pulmonary Diseases"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5298-8442","authenticated-orcid":false,"given":"Mehdi","family":"Mirsaeidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golnaz","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Beth","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2014.05.010_bib1","unstructured":"Prevention CfDCa. Clinical Features: Pneumococcal Disease. Available at: http:\/\/www.cdc.gov\/pneumococcal\/clinicians\/clinical-features.html. Accessed March 6,\u00a02014."},{"key":"10.1016\/j.amjmed.2014.05.010_bib2","unstructured":"CDC. Deaths: Preliminary Data for 2011. Available at: http:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr61\/nvsr61_06.pdf. 2012. Accessed April 3,\u00a02014."},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2014.05.010_bib3","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0264-410X(99)00122-X","article-title":"The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known","volume":"17","author":"Fedson","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.amjmed.2014.05.010_bib4","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1111\/j.1532-5415.2012.04208.x","article-title":"Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population","volume":"60","author":"Yu","year":"2012","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.amjmed.2014.05.010_bib5","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/jcm.33.10.2759-2762.1995","article-title":"Six newly recognized types of Streptococcus pneumoniae","volume":"33","author":"Henrichsen","year":"1995","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.amjmed.2014.05.010_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/317924","article-title":"Invasive pneumococcal disease in England and Wales: vaccination implications","volume":"183","author":"Sleeman","year":"2001","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.amjmed.2014.05.010_bib7","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1513\/AnnalsATS.201401-042CME","article-title":"Pneumococcal vaccines: understanding centers for disease control and prevention recommendations","volume":"11","author":"Mirsaeidi","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.amjmed.2014.05.010_bib8","doi-asserted-by":"crossref","first-page":"22691","DOI":"10.3402\/ijch.v73.22691","article-title":"Impact of pneumococcal vaccines use on invasive pneumococcal disease in Nunavik (Quebec) from 1997 to 2010","volume":"73","author":"Le Meur","year":"2014","journal-title":"Int J Circumpolar Health"},{"key":"10.1016\/j.amjmed.2014.05.010_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1086\/313609","article-title":"The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"1 Pt 1","key":"10.1016\/j.amjmed.2014.05.010_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.110.1.1","article-title":"Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae","volume":"110","author":"Tan","year":"2002","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.amjmed.2014.05.010_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000348","article-title":"Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project","volume":"7","author":"Johnson","year":"2010","journal-title":"PLoS Med"},{"issue":"Suppl 5","key":"10.1016\/j.amjmed.2014.05.010_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/1469-0691.12518","article-title":"Role of vaccination in preventing pneumococcal disease in adults","volume":"20","author":"Aliberti","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.amjmed.2014.05.010_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1473-3099(04)00931-4","article-title":"Pneumonia in the very old","volume":"4","author":"Janssens","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.amjmed.2014.05.010_bib14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7326\/0003-4819-60-5-759","article-title":"Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia","volume":"60","author":"Austrian","year":"1964","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2014.05.010_bib15","series-title":"Active Bacterial Core surveillance report, Emerging Infections Program Network, Streptococcus pneumoniae, 2010","year":"2011"},{"key":"10.1016\/j.amjmed.2014.05.010_bib16","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/lary.21090","article-title":"Racial\/ethnic and socioeconomic disparities in the prevalence and treatment of otitis media in children in the United States","volume":"120","author":"Smith","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.amjmed.2014.05.010_bib17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00006454-199704000-00029","article-title":"Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media","volume":"16","author":"Block","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.amjmed.2014.05.010_bib18","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","article-title":"Bacterial meningitis in the United States, 1998-2007","volume":"364","author":"Thigpen","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjmed.2014.05.010_bib19","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","article-title":"Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era","volume":"285","author":"Robinson","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2014.05.010_bib20","first-page":"1102","article-title":"Advisory Committee on Immunization P. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23)","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amjmed.2014.05.010_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00005792-200007000-00002","article-title":"Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study","volume":"79","author":"Musher","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.amjmed.2014.05.010_bib22","doi-asserted-by":"crossref","first-page":"e7255","DOI":"10.1371\/journal.pone.0007255","article-title":"Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto","volume":"4","author":"Plevneshi","year":"2009","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.amjmed.2014.05.010_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/mdr.1997.3.215","article-title":"Invasive pneumococcal disease in the immunocompromised host","volume":"3","author":"Janoff","year":"1997","journal-title":"Microb Drug Resist"},{"issue":"9785","key":"10.1016\/j.amjmed.2014.05.010_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(10)61493-6","article-title":"Post-splenectomy and hyposplenic states","volume":"378","author":"Di Sabatino","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2014.05.010_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1473-3099(10)70055-4","article-title":"Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis","volume":"10","author":"Ramakrishnan","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.amjmed.2014.05.010_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"187","author":"Vestbo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2014.05.010_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejim.2013.02.013","article-title":"Chronic heart failure and risk of hospitalization with pneumonia: a population-based study","volume":"24","author":"Mor","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.amjmed.2014.05.010_bib28","doi-asserted-by":"crossref","first-page":"e58317","DOI":"10.1371\/journal.pone.0058317","article-title":"Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study","volume":"8","author":"Wang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.amjmed.2014.05.010_bib29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM200003093421002","article-title":"Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team","volume":"342","author":"Nuorti","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjmed.2014.05.010_bib30","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1183\/09031936.00171309","article-title":"Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly","volume":"36","author":"Dominguez","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjmed.2014.05.010_bib31","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.vaccine.2008.11.098","article-title":"Immunological responses to pneumococcal vaccine in frail older people","volume":"27","author":"Ridda","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.amjmed.2014.05.010_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00000441-199007000-00011","article-title":"Pneumococcal vaccination: work to date and future prospects","volume":"300","author":"Musher","year":"1990","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjmed.2014.05.010_bib33","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjmed.2014.05.010_bib34","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1073\/pnas.0501254102","article-title":"CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization","volume":"102","author":"Malley","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.amjmed.2014.05.010_bib35","unstructured":"Administration UFaD. Protection of adults from invasive pneumococcal disease (IPD) by means of active immunization with currently licensed vaccine PNEUMOVAX 23TM (PPV23). Available at: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/05\/briefing\/5-4188b2_4b.pdf. Accessed April 3,\u00a02014."},{"key":"10.1016\/j.amjmed.2014.05.010_bib36","first-page":"744","article-title":"Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides","volume":"10","author":"Biagini","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"RR-11","key":"10.1016\/j.amjmed.2014.05.010_bib37","first-page":"1","volume":"59","author":"Nuorti","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.amjmed.2014.05.010_bib38","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jama.1993.03510150060030","article-title":"Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations","volume":"270","author":"Butler","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2014.05.010_bib39","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1086\/592691","article-title":"Pneumococcal vaccination of elderly adults: new paradigms for protection","volume":"47","author":"Jackson","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2014.05.010_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1086\/653114","article-title":"Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia","volume":"51","author":"Johnstone","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2014.05.010_bib41","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1086\/507699","article-title":"Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia","volume":"43","author":"Musher","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2014.05.010_bib42","first-page":"CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"1","author":"Moberley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2014.05.010_bib43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1086\/318482","article-title":"Immunogenicity of pneumococcal vaccine in heart transplant recipients","volume":"32","author":"Blumberg","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2014.05.010_bib44","doi-asserted-by":"crossref","first-page":"e46133","DOI":"10.1371\/journal.pone.0046133","article-title":"Randomized, single blind, controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in renal transplant recipients","volume":"7","author":"Tobudic","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.amjmed.2014.05.010_bib45","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1086\/523583","article-title":"A\u00a0randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients","volume":"45","author":"Kumar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2014.05.010_bib46","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/165.3.553","article-title":"Antibody to\u00a0capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine","volume":"165","author":"Rodriguez-Barradas","year":"1992","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.amjmed.2014.05.010_bib47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1468-1293.2009.00744.x","article-title":"A\u00a05-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy","volume":"11","author":"Hung","year":"2010","journal-title":"HIV Med"},{"key":"10.1016\/j.amjmed.2014.05.010_bib48","unstructured":"Prevention CfDCa. Recommended immunization schedule for persons aged 0 through 18 years \u2013 United States. Available at: http:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/child\/0-18yrs-schedule.pdf. 2014. Accessed April 3,\u00a02014."},{"key":"10.1016\/j.amjmed.2014.05.010_bib49","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3201\/eid1907.121830","article-title":"Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.)","volume":"19","author":"Richter","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.amjmed.2014.05.010_bib50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MOP.0b013e328341d1f5","article-title":"A\u00a0second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children","volume":"23","author":"Grijalva","year":"2011","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.amjmed.2014.05.010_bib51","unstructured":"Food and Drug Administration (FDA) web site. Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein) Prevnar\u00ae. Available at: http:\/\/www.fda.gov\/downloads\/biologicsbloodvaccines\/vaccines\/approvedproducts\/ucm137038.pdf. Accessed April 3,\u00a02014."},{"key":"10.1016\/j.amjmed.2014.05.010_bib52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.amjmed.2014.05.010_bib53","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jemermed.2013.04.029","article-title":"Emergency department epidemiology of pneumococcal bacteremia in children since the institution of widespread PCV7 vaccination","volume":"45","author":"Mistry","year":"2013","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.amjmed.2014.05.010_bib54","first-page":"521","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amjmed.2014.05.010_bib55","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amjmed.2014.05.010_bib56","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1016\/j.vaccine.2011.05.031","article-title":"A\u00a0randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged >\/=65 years","volume":"29","author":"Schwarz","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.amjmed.2014.05.010_bib57","first-page":"258","article-title":"Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for\u00a0use among children - Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amjmed.2014.05.010_bib58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.idc.2012.11.011","article-title":"How effective is vaccination in preventing pneumococcal disease?","volume":"27","author":"Musher","year":"2013","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.amjmed.2014.05.010_bib59","unstructured":"Food and Drug Administration. FDA expands use of Prevnar 13 vaccine for people ages 50 and older. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration. Available at: http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm285431.htm?source=govdelivery. Accessed March 28,\u00a02014."},{"key":"10.1016\/j.amjmed.2014.05.010_bib60","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1016\/j.vaccine.2013.04.085","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.amjmed.2014.05.010_bib61","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1016\/j.vaccine.2013.06.037","article-title":"Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults","volume":"31","author":"Smith","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.amjmed.2014.05.010_bib62","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1016\/j.vaccine.2013.10.024","article-title":"Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions","volume":"31","author":"Cho","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.amjmed.2014.05.010_bib63","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/cid\/cit640","article-title":"Effects of immunocompromise and comorbidities on pneumococcal serotypes causing invasive respiratory infection in adults: implications for vaccine strategies","volume":"57","author":"Lujan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2014.05.010_bib64","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2014.05.010_bib65","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/INF.0b013e3182480fed","article-title":"Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population","volume":"31","author":"Ellison","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.amjmed.2014.05.010_bib66","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3109\/08880018.2013.786157","article-title":"Prevalence of pneumococcal bacteremia in children with sickle cell disease","volume":"30","author":"Patel","year":"2013","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.amjmed.2014.05.010_bib67","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1378\/chest.10-0317","article-title":"Pulmonary complications of hemoglobinopathies","volume":"138","author":"Vij","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2014.05.010_bib68","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaci.2007.08.053","article-title":"Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee","volume":"120","author":"Geha","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl A","key":"10.1016\/j.amjmed.2014.05.010_bib69","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1016\/S1526-0542(04)90043-7","article-title":"Pulmonary complications of primary immunodeficiencies","volume":"5","author":"Buckley","year":"2004","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.amjmed.2014.05.010_bib70","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1399-3038.2010.01118.x","article-title":"Detection of pulmonary complications in common variable immunodeficiency","volume":"22","author":"Turner","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.amjmed.2014.05.010_bib71","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1399-3038.2009.00963.x","article-title":"Detection of pulmonary complications in common variable immunodeficiency","volume":"21","author":"Touw","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.amjmed.2014.05.010_bib72","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00130832-200312000-00006","article-title":"Primary immunodeficiencies associated with pneumococcal disease","volume":"3","author":"Picard","year":"2003","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.amjmed.2014.05.010_bib73","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.iac.2008.01.009","article-title":"From infectious diseases to primary immunodeficiencies","volume":"28","author":"Bustamante","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.amjmed.2014.05.010_bib74","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease. Report on a national registry of 368 patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.amjmed.2014.05.010_bib75","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccm.2013.01.009","article-title":"Human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"34","author":"Barnett","year":"2013","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.amjmed.2014.05.010_bib76","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/rccm.200404-445OC","article-title":"Bosentan for the treatment of\u00a0human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"170","author":"Sitbon","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2014.05.010_bib77","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ccm.2013.01.008","article-title":"Human immunodeficiency virus-associated lung malignancies","volume":"34","author":"Lambert","year":"2013","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.amjmed.2014.05.010_bib78","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1179\/146532807X245625","article-title":"HIV-related pulmonary disorders: practice issues","volume":"27","author":"Graham","year":"2007","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.amjmed.2014.05.010_bib79","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ccm.2013.02.002","article-title":"Human immunodeficiency virus-associated obstructive lung diseases","volume":"34","author":"Gingo","year":"2013","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.amjmed.2014.05.010_bib80","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5588\/ijtld.11.0244","article-title":"HIV-related bronchiectasis in children: an emerging spectre in high tuberculosis burden areas","volume":"16","author":"Masekela","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.amjmed.2014.05.010_bib81","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1016\/j.vaccine.2013.04.065","article-title":"Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in\u00a0HIV-infected adults in Brazil","volume":"31","author":"Ho","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.amjmed.2014.05.010_bib82","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1017\/S0950268810000919","article-title":"Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies","volume":"138","author":"Wong","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.amjmed.2014.05.010_bib83","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2141.2007.06601.x","article-title":"Increased risk for invasive pneumococcal diseases in children with acute lymphoblastic leukaemia","volume":"137","author":"Meisel","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2014.05.010_bib84","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1469-0691.2009.02810.x","article-title":"The epidemiology of\u00a0invasive Streptococcus pneumoniae infections in onco-haematology and haematopoietic stem cell transplant patients in France. Are the serotypes covered by the available anti-pneumococcal vaccines?","volume":"15","author":"Debbache","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.amjmed.2014.05.010_bib85","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s10067-011-1856-5","article-title":"Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs","volume":"30","author":"Kapetanovic","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.amjmed.2014.05.010_bib86","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11908-011-0183-y","article-title":"TNF-alpha antagonists and immunization","volume":"13","author":"Visser","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.amjmed.2014.05.010_bib87","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MCP.0b013e3283642ad0","article-title":"Nonsteroidal therapy of sarcoidosis","volume":"19","author":"Korsten","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.amjmed.2014.05.010_bib88","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/CVI.00176-12","article-title":"Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults","volume":"19","author":"Frenck","year":"2012","journal-title":"Clin Vaccine Immunol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934314003969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934314003969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:02:13Z","timestamp":1757581333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934314003969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":88,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0002934314003969"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2014.05.010","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal Vaccine and Patients with Pulmonary Diseases","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2014.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}